FEMARA® (letrozole) - Summary of Product Characteristics
Click below to download the FEMARA® Summary of Product Characteristics for the following European countries
- Austria
- Belgium
- Denmark
- Finland
- France
- Germany
- Greece
- Ireland
- Italy
- Luxembourg
- Netherlands
- Portugal
- Spain
- Sweden
Femara® (letrozole) Summary of Product Characteristics - Europe (PDF)
Please note: The information in this Summary of Product Characteristic is valid for the countries listed above and may contain information that is outside the approved product information in the country in which you are located. Please contact your local Novartis affiliate or visit your country site (where available) for obtaining specific product information for your country.
For more details on early and long-term benefits seen with FEMARA® in the pivotal BIG 1-98 trial, click here.
